KZIA
Kazia Therapeutics Ltd
9.30$
-2.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +890.3% | -23.0% | +1.1% | -21.5% | -24.8% | +8.9% | +151.9% | -38.2% | -21.7% | -23.1% | -71.9% | |
| – | +1,592.5% | -23.6% | -42.9% | -52.5% | -18.6% | +41.2% | +175.9% | -67.9% | +14.0% | -43.0% | -19.7% | |
| – | +1,673.4% | -24.6% | -56.8% | -58.8% | -8.8% | +61.3% | +214.8% | -73.3% | -28.8% | -68.4% | +162.2% | |
| – | +1,673.4% | -24.6% | -56.8% | -58.8% | -8.4% | +60.7% | +214.8% | -73.3% | -28.8% | -68.4% | +162.2% | |
| – | -96.8% | +4,450.0% | -94.4% | -77.7% | +137,739.4% | -100.0% | +17,212.1% | -32.9% | +105.9% | +26.7% | -32.3% | |
| – | – | – | -100.0% | -100.0% | – | – | -8,400,000.0% | – | – | – | – | |
| – | +466.9% | +802.5% | -17.3% | -99.8% | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -29.1% | -40.9% | +1,836.5% | -8.4% | -7.4% | -8.0% | +77.3% | -13.0% | -9.8% | -10.8% | -92.9% | |
| – | -45.3% | -10.8% | +566.6% | -15.5% | -21.6% | +27.5% | +126.4% | -13.0% | -9.0% | +97.1% | -54.6% | |
| – | -45.3% | -19.4% | +276.0% | -27.8% | -43.2% | +129.6% | +64.3% | -19.2% | +12.4% | +241.0% | -45.5% | |
| – | -100.0% | – | +0.0% | +740.0% | -100.0% | – | – | – | -2.4% | -64.7% | -37.5% | |
| – | +845.1% | -33.1% | +143.9% | +12.7% | -25.4% | +61.3% | +11.8% | -19.5% | -43.8% | +430.7% | +24.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +2,856.5% | -24.0% | -25.3% | -24.1% | -26.2% | -0.5% | +168.0% | -51.7% | -34.1% | -183.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +50.8% | +79.3% | +9.5% | +3.4% | +18.9% | +27.0% | +54.4% | +12.6% | +39.1% | +30.1% | +128.4% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.